Skip to content
GLP-1 Decoder

Rybelsus for Breastfeeding: Evidence, Eligibility, Coverage

The Rybelsus label on breastfeeding: The tablets and breast milk both contain SNAC.

Active ingredient
semaglutide
How it is taken
daily tablet

Rybelsus in brief

How long it remains in your body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week: after 7 d, half is gone, and after five half-lives (35 d), about 3% remains.

Weight loss in the main trial
Rybelsus (PIONEER 1)3.7 kgPlacebo1.4 kg

In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks. Placebo resulted in a loss of 1.4 kg.

What prices look like over time
20262027$1,027.51$0List priceSelf-pay

Monthly prices in US dollars show the list price and self-pay offers. Each one is listed on the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.

Breastfeeding advice in the Rybelsus label

Rybelsus label: breastfeeding
MedicineWhat the label says
RybelsusThe tablets and breast milk both contain SNAC.

The FDA label (DailyMed) provides these details.

These warnings come from the FDA label (DailyMed).

Each GLP-1 label on breastfeeding

GLP-1 medicines and breastfeeding
MedicineWhat the label saysHow it is taken
RybelsusThe tablets and breast milk both contain SNAC.daily tablet
OzempicIt is unknown whether this medicine enters human breast milk.weekly injection
WegovyThe tablets and breast milk both contain SNAC; for the injection, passage into breast milk is not known.weekly injection or daily tablet
MounjaroA small study found undetectable or low levels in breast milk.weekly injection
ZepboundA small study found undetectable or low levels in breast milk.weekly injection
FoundayoIt is unknown whether this medicine enters human breast milk.daily tablet
TrulicityIt is unknown whether this medicine enters human breast milk.weekly injection
SaxendaIt is unknown whether this medicine enters human breast milk.daily injection
VictozaIt is unknown whether this medicine enters human breast milk.daily injection
ByettaIt is unknown whether this medicine enters human breast milk.twice-daily injection

Source: FDA label (DailyMed).

Questions to ask your prescriber

Read Rybelsus information on DailyMed for all prescribing details.